Is Kenvue Inc. a good investment? Kenvue Inc. (KVUE) is currently trading at 19.01 USD. Market analysts have a consensus price target of 19.83 USD. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 22.90. This valuation is generally in line with the broader market.
Earnings Schedule: Kenvue Inc. is expected to release its next earnings report on Aug. 6, 2026. The market consensus estimate for Forward EPS is 1.24.
For income investors, Kenvue Inc. pays a dividend yield of 4.40%. With a payout ratio of 0%, the dividend appears sustainable.
Yes, it pays an annual dividend of 0.83 USD (4.40% yield).
Kenvue Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
The next earnings date is projected to be Aug. 6, 2026. The company currently has a trailing EPS of 0.84.
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
| Year | Total Dividends |
|---|---|
| ▸2027 |
0.42 USD
|
| May 26, 2027 (estimated) | 0.2080 |
| Feb. 24, 2027 (estimated) | 0.2080 |
| ▸2026 |
0.84 USD
|
| Nov. 25, 2026 (estimated) | 0.2132 |
| Aug. 26, 2026 | 0.2100 |
| May 27, 2026 | 0.2080 |
| Feb. 25, 2026 | 0.2080 |
| ▸2025 |
0.83 USD
|
| Nov. 26, 2025 | 0.2080 |
| Aug. 27, 2025 | 0.2080 |
| May 28, 2025 | 0.2050 |
| Feb. 26, 2025 | 0.2050 |
| ▸2024 |
0.81 USD
|
| Nov. 27, 2024 | 0.2050 |
| Aug. 28, 2024 | 0.2050 |
| May 22, 2024 | 0.2000 |
| Feb. 28, 2024 | 0.2000 |
| ▸2023 |
0.40 USD
|
| Nov. 22, 2023 | 0.2000 |
| Sept. 7, 2023 | 0.2000 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Kenvue Inc. | Aug 26, 2026 | Upcoming | 0.21 USD |
| Kenvue Inc. | May 27, 2026 | Paid | 0.208 USD |
| Kenvue Inc. | Feb 25, 2026 | Paid | 0.208 USD |
| Kenvue Inc. | Nov 26, 2025 | Paid | 0.208 USD |
| Kenvue Inc. | Aug 27, 2025 | Paid | 0.208 USD |
Community Discussion